Association of Circulating Tumor DNA Testing Before Tissue Diagnosis With Time to Treatment Among Patients With Suspected Advanced Lung Cancer: The ACCELERATE Nonrandomized Clinical Trial

IMPORTANCE: Liquid biopsy has emerged as a complement to tumor tissue profiling for advanced non–small cell lung cancer (NSCLC). The optimal way to integrate liquid biopsy into the diagnostic algorithm for patients with newly diagnosed advanced NSCLC remains unclear. OBJECTIVE: To evaluate the use o...

Descripción completa

Detalles Bibliográficos
Autores principales: García-Pardo, Miguel, Czarnecka-Kujawa, Kasia, Law, Jennifer H., Salvarrey, Alexandra M., Fernandes, Roxanne, Fan, Zhen J., Waddell, Thomas K., Yasufuku, Kazuhiro, Liu, Geoffrey, Donahoe, Laura L., Pierre, Andrew, Le, Lisa W., Gunasegaran, Tharsiga, Ghumman, Noor, Shepherd, Frances A., Bradbury, Penelope A., Sacher, Adrian G., Schmid, Sabine, Corke, Lucy, Feng, Jamie, Stockley, Tracy, Pal, Prodipto, Rogalla, Patrik, Pipinikas, Christodoulos, Howarth, Karen, Ambasager, Bana, Mezquita, Laura, Tsao, Ming S., Leighl, Natasha B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10369925/
https://www.ncbi.nlm.nih.gov/pubmed/37490292
http://dx.doi.org/10.1001/jamanetworkopen.2023.25332

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10369925/
https://www.ncbi.nlm.nih.gov/pubmed/37490292
http://dx.doi.org/10.1001/jamanetworkopen.2023.25332

Ejemplares similares